Impact of the interfraction interval on clonogenic cell survival in split-dose irradiation of R1H rhabdomyosarcoma of the rat in vitro

Radiotherapy and Oncology

Volumn 43, Issue 1, 1997, Pages 93-96

  Willers, Henning ^a,b   Prosch, Barbara ^b   Beck Bornholdt, Hans Peter ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

cell cycle effects; cell survival; fractionation; interfraction interval; R1H rhabdomyosarcoma

Indexed keywords

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RAT; RHABDOMYOSARCOMA; TUMOR CELL CULTURE;

EID: 0030981829     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)01941-5     Document Type: Article

References (13)

1. Ang, K.K., Jiang, G.L., Guttenberger, R. et al. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiother. Oncol. 25: 287-294, 1992.
2. Beck-Bornholdt, H.-P. and Dubben, H.-H. Potential pitfalls in the use of P-values and in interpretation of significance levels. Radiother. Oncol. 33: 171-176, 1994.
3. Beck-Bornholdt, H.-P., Würschmidt, F. and Vogler, H. Net growth delay: a novel parameter derived from tumor growth curves. Int. J. Radiat. Oncol. Biol. Phys. 13: 773-777, 1987.
4. Elkind, M.M., Sutton-Gilbert, H., Moses, W.B., Alescio, T. and Swain, R.W. Radiation response of mammalian cells grown in culture. V. Temperature dependence of the repair of X-ray damage in surviving cells (aerobic and hypoxic). Radiat. Res. 25: 359-376, 1965.
5. Fu, K.K., Pajak, T.F., Martial, V.A. et al. Late effects of hyperfrac-tionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int. J. Radiat. Oncol. Biol. Phys. 32: 577-588, 1995.
6. Jeremic, B. and Shibamoto, Y. Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 34: 303-308, 1996.
7. Kleineidam, M., Pieconka, A. and Beck-Bornholdt, H.-P. Radiotherapy of the R1H rhabdomyosarcoma of the rat: influence of the time interval between two daily fractions during hyperfractionated radiotherapy. Radiother. Oncol. 30: 128-132, 1994.
8. Ling, C.C., Guo, M., Chen, C.H. and Deloherey, T. Radiation-induced apoptosis: effects of cell age and dose fractionation. Cancer Res. 55: 5207-5212, 1995.
9. Marcial, V.A., Pajak, T.F., Chu, C., Tupchong, L. and Stetz, J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int. J. Radiat. Oncol. Biol. Phys. 13: 41-47, 1987.
10. Nelson, D.F., Curran, W.J., Scott, C. et al. Hyperfractionated radiation therapy and bis-chlorethyl nitrosurea in the treatment of malignant glioma - Possible advantage observed at 72.0 Gy in 1.2 Gy b.i.d. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int. J. Radiat. Oncol. Biol. Phys. 25: 193-207, 1993.
11. Nyman, J. and Turesson, I. Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions. Radiother. Oncol. 34: 171-178, 1995.
12. Thames, H.D. and Hendry, J.H. Fractionation in radiotherapy. Taylor and Francis, London, 1987.
13. Vogler, H. and Beck-Bornholdt, H.-P. Radiotherapy of the rhabdomyosarcoma R1H of the rat: kinetics of cellular inactivation by fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 14: 317-325, 1988.